The Diagnoses and Outcomes of Emergency Patients With an Elevated D-Dimer Over the Next 90 Days
- PMID: 32663451
- PMCID: PMC7354269
- DOI: 10.1016/j.amjmed.2020.06.009
The Diagnoses and Outcomes of Emergency Patients With an Elevated D-Dimer Over the Next 90 Days
Abstract
Background: It is not known what diagnoses are associated with an elevated D-dimer in unselected patients attending emergency departments (ED), nor have their associated outcomes been determined.
Methods: This was a prospective observational study of 1612 unselected patients attending a Danish ED, with 100% follow-up for 90 days after presentation.
Results: The 765 (47%) ED patients with an elevated D-dimer level (ie, ≥ 0.5 mg/L) were more likely to be admitted to hospital (P <.0001), re-present to health services (P = .02), and die within 90 days (8.1% of patients, P <.0001). Only 10 patients with a normal D-dimer level (1.2%) died within 90 days. Five had chronic obstructive pulmonary disease and infection, and 5 had cancer (4 of whom also had infection). Venous thromboembolism, infection, neoplasia, anemia, heart failure, and unspecified soft tissue disorders were significantly associated with an elevated D-dimer level. Of the 72 patients with venous thromboembolism, 20 also had infection, 8 had cancer, and 4 had anemia. None of the patients with heart failure, stroke, or acute myocardial infarction with a normal D-dimer level died within 90 days.
Conclusions: In this study, nearly half of all patients attending the ED had an elevated D-dimer level, and these patients were more likely to be admitted to hospital and to re-present to health services or die within 90 days. In this unselected ED patient population, elevated D-dimer levels were found to not only be significantly associated with venous thromboembolism, but to also be associated with infection, cancer, heart failure, and anemia.
Keywords: Cancer; D-dimer; Diagnoses; Infection; Mortality; Prognosis; Unselected emergencies.
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures
Comment in
-
The Jury Is Still Out on Routine Use of D-Dimer in Medical Illness.Am J Med. 2021 Aug;134(8):e471. doi: 10.1016/j.amjmed.2021.02.027. Am J Med. 2021. PMID: 34340759 No abstract available.
-
The Reply.Am J Med. 2021 Aug;134(8):e472. doi: 10.1016/j.amjmed.2021.03.019. Am J Med. 2021. PMID: 34340760 Free PMC article. No abstract available.
References
-
- Querol-Ribelles JM, Tenias JM, Grau E. Plasma D-dimer levels correlate with outcomes in patients with community-acquired pneumonia. Chest. 2004;126(4):1087–1092. - PubMed
-
- Szymanski FM, Karpinski G, Filipiak KJ. Usefulness of the D-dimer concentration as a predictor of mortality in patients with out-of-hospital cardiac arrest. Am J Cardio. 2013;112:467–471. - PubMed
-
- Goldhaber SZ, Vaughn DE, Tumeh SS, Loscalzo J. Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J. 1988;116:505–508. - PubMed
-
- Mager JJ, Schutgens RE, Haas FJ, Westermann CJ, Biesma DH. The early course of D-dimer concentration following pulmonary artery embolisation. Thromb Haemost. 2001;86:1578–1579. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources